Skip to Main Content

Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis

Conditions

Immune System | Rheumatology/Scleroderma

What is the purpose of this trial?

The purpose of this research study is to better understand the development of systemic sclerosis (SSc)/scleroderma-related lung fibrosis (scarring)/interstitial lung disease (ILD) and how the development of scleroderma lung disease might be associated with scleroderma skin and esophageal disease. Study procedures will include: screening form, blood collection, skin biopsy collection, suture removal, and bronchoscopy.

  • Trial with
    National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)
  • Start Date
    06/01/2019
  • End Date
    12/31/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000024862